EMEA-001856-PIP02-16-M02
Key facts
| Invented name |
Alpivab
|
| Active substance |
Peramivir
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0257/2021
|
| PIP number |
EMEA-001856-PIP02-16-M02
|
| Pharmaceutical form(s) |
Concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of influenza
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
BioCryst Ireland Limited
Tel. +1 9194505809 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001856-PIP02-16-M02
|
| Compliance opinion date |
17/12/2021
|
| Compliance outcome |
positive
|